We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Lifeline Sci. S | LSI | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 137.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 137.00 |
| Top Posts |
|---|
Posted at 29/5/2014 09:45 by affemoose And who do you think has been badgering the CFO and their Investor Relations lady for something in London for about 3 years now?Moi And who, by an excellent stroke of sods law, was on holidays when it happened? Moi DOH! I suppose I should be grateful for small mercies, you are right. Enough of the grumps Affe |
Posted at 11/11/2013 09:20 by affemoose Good to see an Investment major voting with their wallets today. Legal and general now own over 5%.Agree with 2vdm - the comms in this company are just awful. FWIW I have contacted them directly in the past, spoken on the phone and email to their Investor Comms people, their press people and the CFO and expressed a desire to see better comms, and investor roadshow in the UK, perhaps the AGM in London? More RNS's wrt major milestones (like being granted Brazilian licenses) etc etc etc And guess what? - Nothing whatsoever. But they are a decent company with very high barriers to competitive entry so I will hold at the price I have and go back to sleep. (looking forward to the paint drying machine!!) |
Posted at 29/7/2013 10:38 by sailing john Yes crackers! you would think they were different businesses looking at the price differential .....again! A lovely quiet board here as LSI/LSIC moves from development to commercial sales mode with a giant pot of tax losses to utilise as a nice bonus. Kidney transporter growing territories, liver transporter progressing towards approval and launch. I guess investors will catch up with the story when the numbers become more obvious in a couple of years. A very, very long term hold for me. From last year's accounts "Our Future The future for Lifeline Scientific and our LifePort brand is strong, and we remain optimistic about continued growth. As global demand for organ transplants continues to increase, market and technological drivers create compelling requirements for scientifically proven solutions to improve donor organ availability and transplantation outcomes. Whether through new product development, geographic expansion or strategic acquisitions, we are committed to achieving sustainable profitable growth, while supporting the global transplant community in their efforts to save the lives of patients suffering from end-stage organ disease. We are moving into an exciting stage of the Company's growth that expects to see reduced R&D spend with an increased focus on commercial sales and marketing. Investments we have undertaken to further strengthen our market leadership will continue to afford us significant opportunity to build profits and value for our investors in the short, medium and longer-term. David Kravitz Chief Executive Officer" |
Posted at 10/12/2012 14:49 by bradjeff My main issue here is that the BoD don't seem to give 2 hoots about investors. I have (several times) asked them to do a London based roadshow to increase visibility of them, to increase RNS flow to hilight milestones rather than just await 6monthly reports etc.But no reply - not one. S-i-l-e-n-c-e They do have a corp comms lady, v nice, but seemingly powerless to a BoD that ignores investors. Sad, and why I am not in, far far too illiquid and low newsworthy. |
Posted at 06/2/2012 07:58 by 2vdm Well finally we get some news from the company and it look like they are making headway. It would be good if they could keep us more regularly updated on how they are progressing. Perhaps they ought to take a leaf out of Simon Tucker's book over at SRT. He keeps investors updated with a 1/4ly webcastand & personally, as an investor, I find this both helpful and feel to be a part of the company. I will stay in here for the time being, because LSI seems to be making progress, but as the above poster said, their investor relations are less than satisfactory. |
Posted at 12/10/2011 11:53 by affemoose An email I sent to LSI. Needless to say, I didn't get a response. And outlines why even the blatant ramping of RHPS (TB owns LSI himself) will fail to bring me back to the fold as a shareholder:I sent to to the CEO and CFO Good afternoon, I hope you don't mind me reaching out to you. Please view these comments as an attempt to have an open frank dialogue. It is with regret that chose to exit from Lifeline shares shortly after your annual results a few months ago. The reason is simple - I knew there would be no news flow (history has proven that), low volumes and the price would drop - I was correct but from a corporate responsibility to shareholders - it is relatively easily solved: 1. You are too illiquid - a 1:5 split would work wonders for you, increase the owner base, get more PI's in (the lifeblood of liquidity) etc etc 2. Your news flow is begrudging to say the least. News breaths life into share price, many companies understand this, it would appear that Lifeline does not. or doesn't care. Surely you have hit some milestones in the last 12-24 months that would have warranted an RNS? Instead all we see are regulatory announcements. I know that the next thing of any interest to me will be the half year results. As an example, look here ( )and see when the last non trading update/results RNS was???? I'll tell you - Lifeline Announces CTS Grant Award 17, August 2009 . 2009 - Surely something positive has happened since then that will inform your shareholders and wake up the wider market? 3. Visibility. the only way I ever heard from you was via a tip sheet, not through your own marketing, brokers activity etc etc. Increasing numbers from the tip sheets are disappearing as shareholders due to reason 1 & 2 above. Your AGM's are in Illinois - nobody in London has any reason whatsoever to get enthused by you, or to have heard of you. Can you have an open day in London perhaps? rent a room in a hotel in the City, and invite all comers, do some PR talks to some of the high profile organisations like Motley Fool, Sharecrazy, Interactive Investor, The Right Side, Brokerman Daniel etc etc? I would love to see Lifeline in my portfolio in the future, and as a business it has a great deal going for it. But your present company approach to the markets and your shareholders is simply not allowing true recognition of value, and without value being recognised, it will not be a good investment. I know the markets are tough at the moment, but I believe you have dropped more than necessary because of the points above. look at the volumes of shares being traded - they are tiny. I hope that you manage to get sound(er) broker advice to address your current (unnecessary) malaise. Yours XXXXXXXXXX |
Posted at 12/5/2011 08:17 by scrutable I am not at all concerned with the cashless transfer of items across the accounts, but mainly with the profitability of the business and very rapid building of infrastructure, adding which will underpin predictable future sales increases at low risk.The key facts IN ORDER OF IMPORTANCE are: * substantial marketing development with footholds gained(in probable descending order of magnitude): CHINA ,BRAZIL, FRANCE, SAUDI ARABIA, UK, ITALY, SWEDEN, POLAND, CZECH REP, * 40% increase from 30 to 42 units sold *capitalisation of only £17m yet operating income up by 61% from $2.82m to to $4.53m * operating cash flow up by 179% from $1.53m to $$4.27m * cash at the bank up by 261% from $3.07m to $11.07m * total sales were up 28% - not at all bad but not as good as hoped for * development of Lifeport Liver Transporter * China, with a population 2.5 x those of Europe and the US combined, is adopting a Western style approach to organ donation. The health budget there was increased by an average 14.2 % adding $80 billion to it between 2009/2011. The only downside risk I can see is that development of the liver Transporter may be more fraught than is in the price. I doubt whether success with this next stage will come easily and cheaply, and without risk. However with diabetes a mass epidemic destroying kidneys at a furious rate, the existing kidney based business could grow and grow for decades This is not a company which has much to say - it is almost taciturn,. Even the AGM in June is being held on June 16 at Itasca, Illinois, so not many of us will be there. - but IMO this an investment of low volatility, which you can put in a drawer and forget. This business has universal appeal. Demand is not going to fluctuate with the economic cycle, and the top slice of society which always seems to defy economic gravity will, however high the cost of food or fuel, always have money to save its own life. Finally there is an acute global shortage of viable organs for transplantation and this company's products makes far more of these organs available - increasingly so as their research and development achieves similar results for human livers, pancreases, and goodness knows what other bits. At 60% /pa stable growth for a technically based and proprietary global product and service, in substantial deficit as far as the eye can see, this is an even better bet for investors than it was last year |
Posted at 28/1/2011 14:03 by pejaten SHARE TIP SUMMARY:Buy Trying to find value in the shares of medical devices companies could be difficult this year as healthcare investors, and particularly venture capital funds, have built up holdings to offset underperforming pharmaceuticals shares. That said, Lifeline's shares are rated a touch below the healthcare equipment sector of 14 time earnings and, if growing revenues stream into profits, sooner or later investors will start to notice. Buy. |
Posted at 28/1/2011 12:18 by envirovision Tipped in todays investor chronicle, though they have tipped the LSCI ticker instead of the LSI one which is wrong as it should be LSICI guess there will be a lot of confused people trying to buy next week. |
Posted at 26/11/2010 10:32 by 2vdm Article from RHPS update on 18th Nov... "Now before I come to the week's news I want to make one other change. This is to raise the buy limit on LIFELINE SCIENTIFIC (LSI) from 200p to 230p.In my opinion, Lifeline is the best share in the entire stock market, bar none. Its human organ transporter is a fantastic product for which there is a massive need worldwide. It has no competition, and the business is already selling and making a profit. The shares have a low profile, partly because they are not being properly promoted by their City advisers. And the fact that you may need to fill in a form for the US authorities - although just a formality - is enough to deter some investors. The final reason why the shares are hard to buy is that nobody wants to sell. Why would they? This is a terrific investment and the valuation is very reasonable. My target is 400p, so BUY UP TO 230p" |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
